PATRICIA BAXTER to Proto-Oncogene Proteins B-raf
This is a "connection" page, showing publications PATRICIA BAXTER has written about Proto-Oncogene Proteins B-raf.
Connection Strength
0.086
-
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial. Nat Med. 2024 Jan; 30(1):207-217.
Score: 0.050
-
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Lancet Oncol. 2019 07; 20(7):1011-1022.
Score: 0.037